7 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Initiative (PAMI) - Opioid ... Equianalgesic Chart - Agents ... and Dosing #Management ... Conversion #Doses #Dosing ... #Table #PAMI
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents ... #Pharmacology #Dosing ... #Dosing #Renal ... #Impairment #CKD
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI) - Non-Opioid ... Analgesics - Agents ... and Dosing #Management ... Medications #Doses #Dosing ... #Table #PAMI
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
adults, <3g in CKD ... avoid NSAIDs if CKD ... • Neuropathic agents ... #Conversion #Table ... #pharmacology #agents
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... phosphate binding agents ... since they are not able ... Purposes Only* #CKD ... Hyperphosphatemia #Dose #Dosing
The first three letters refer to chamber paced, chamber sensed, and response to sensed events. The
response to sensed events ... Pacemaker #LetterCode #Coding ... #Classification ... #Table
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
anti-Smith Ab, low complements ... Skin Disease Classification ... pancreatitis, protein-losing ... Valvular disorders • CAD ... RNP antibodies, Complement